FDA Drug Application (020591) for TARKA by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number020591
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage2MG;180MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTARKA
Active IngredientTRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient TRANDOLAPRIL4
List of drugs with Active Ingredient VERAPAMIL HYDROCHLORIDE10


Back to FDA Applications sponsored by ABBVIE